Back to Trades
Apimeds Pharmaceuticals US, Inc.
APUSCIK: 0001894525
Follow APUS
Track Apimeds Pharmaceuticals US, Inc. insider trades on your dashboard. Email alerts with a subscription.
Apimeds Pharmaceuticals US, Inc. (APUS) has recorded 12 insider filings from 8 unique insiders, totaling $575.1K in trading activity (balanced activity). Insider purchases and sales are approximately balanced over this period. The most active insider by volume is Emerson Erik C.. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$575.1K
Purchases
$0
Sales
$0
Unique Insiders
8
Recent Insider Trades
12 loaded
| Nov 13 | APUS Apimeds Pharmaceuticals US, Inc. | Yoon Hankil | Director | Other | $0 |
| Nov 13 | APUS Apimeds Pharmaceuticals US, Inc. | Kogan Elona | Director | Other | $0 |
| Nov 13 | APUS Apimeds Pharmaceuticals US, Inc. | Koo Jakap | Director | Other | $0 |
| Nov 13 | APUS Apimeds Pharmaceuticals US, Inc. | O'DONNELL CAROL A | Director | Other | $0 |
| Nov 13 | APUS Apimeds Pharmaceuticals US, Inc. | Weintraub Bennett | Director | Other | $0 |
| Oct 17 | APUS Apimeds Pharmaceuticals US, Inc. | Kim Christopher | Chairman and CMO, Director | Other | $0 |
| Oct 17 | APUS Apimeds Pharmaceuticals US, Inc. | Yoon Hankil | Director | Other | $0 |
| Oct 17 | APUS Apimeds Pharmaceuticals US, Inc. | Koo Jakap | Director | Other | $0 |
| Oct 24 | APUS Apimeds Pharmaceuticals US, Inc. | Kogan Elona | Director | Other | $0 |
| Oct 17 | APUS Apimeds Pharmaceuticals US, Inc. | Weintraub Bennett | Director | Other | $0 |
| Oct 17 | APUS Apimeds Pharmaceuticals US, Inc. | Emerson Erik C. | Chief Executive Officer, Director | Other | $0 |
| Nov 21 | APUS Apimeds Pharmaceuticals US, Inc. | Inscobee Inc. | 10% Owner | Other | $0 |
12 filings